Evidence map›Paper›PMID 29792309›Full record

ArticleCancer research2018

Metabolic and Physiologic Imaging Biomarkers of the Tumor Microenvironment Predict Treatment Outcome with Radiation or a Hypoxia-Activated Prodrug in Mice.

Shingo Matsumoto, Shun Kishimoto, Keita Saito, Yoichi Takakusagi, Jeeva P Munasinghe, Nallathamby Devasahayam, Charles P Hart, Robert J Gillies, James B Mitchell, Murali C Krishna

Open access · greenAbstract read
In one paragraph

Article in Cancer research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. The role of NADFrontiers in oncology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Oxygen-Sensitive MRI: A Predictive Imaging Biomarker for Tumor Radiation Response?International journal of radiation oncology, biology, physics · 2021
    Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Shingo MatsumotoRadiation Biology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
Shun KishimotoRadiation Biology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.ORCID 0000-0002-2496-5283
Keita SaitoRadiation Biology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
Yoichi TakakusagiRadiation Biology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
Jeeva P MunasingheMouse Imaging Facility, National Institute of Neurological Disorder and Stroke, NIH, Bethesda, Maryland.
Nallathamby DevasahayamRadiation Biology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
Charles P HartThreshold Pharmaceutical, San Francisco, California.
Robert J GilliesDepartment of Imaging and Metabolism, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.ORCID 0000-0002-8888-7747
James B MitchellRadiation Biology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
Murali C KrishnaRadiation Biology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland. murali@helix.nih.gov.
National Cancer Institute · USHokkaido University of Science · JPMoffitt Cancer Center · USNational Institute of Neurological Disorders and Stroke · USNational Institutes for Quantum Science and Technology · JPThreshold Pharmaceuticals (United States) · US

Funding

Time Domian Electron Paramagnetic Resonance ImagingZIABC010476 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHERUKURI, MURALI · 2009 to 2025
$17.9M
Time Domian Electron Paramagnetic Resonance ImagingZ01BC010476 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHERUKURI, MURALI · 2003 to 2008
$1.7M
Intramural NIH HHS Z01 BC010476
6 · The paper itself

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is characterized by hypoxic niches that lead to treatment resistance. Therefore, studies of tumor oxygenation and metabolic profiling should contribute to improved treatment strategies. Here, we define two imaging biomarkers that predict differences in tumor response to therapy: (i) partial oxygen pressure (pO

Indexed as

AnimalsBiomarkers, TumorCarcinoma, Pancreatic DuctalCell Line, TumorCombined Modality TherapyDeoxycytidineGemcitabineHumansHypoxiaMiceMice, NudeOxygenPancreatic NeoplasmsProdrugsTreatment OutcomeTumor MicroenvironmentBiomarkers, TumorDeoxycytidineGemcitabineOxygenProdrugs

Identifiers

PMID29792309
PMCPMC8092078
OpenAlexW2803472528

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.